CFI
Summary: This gene encodes a serine proteinase that is essential for regulating the complement cascade. The encoded preproprotein is cleaved to produce both heavy and light chains, which are linked by disulfide bonds to form a heterodimeric glycoprotein. This heterodimer can cleave and inactivate the complement components C4b and C3b, and it prevents the assembly of the C3 and C5 convertase enzymes. Defects in this gene cause complement factor I deficiency, an autosomal recessive disease associated with a susceptibility to pyogenic infections. Mutations in this gene have been associated with a predisposition to atypical hemolytic uremic syndrome, a disease characterized by acute renal failure, microangiopathic hemolytic anemia and thrombocytopenia. Primary glomerulonephritis with immune deposits and age-related macular degeneration are other conditions associated with mutations of this gene. [provided by RefSeq, Dec 2015].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
complement factor I | MIM:217030 | Ensembl:ENSG00000205403 | HGNC:HGNC:5394 | PA29641 | 4q25 |
GO terms in CFI
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | TAS | GO:0004252 | serine-type endopeptidase activity |
MF | IEA | GO:0005044 | scavenger receptor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0046872 | metal ion binding |
BP | IEA | GO:0006508 | proteolysis |
BP | IEA | GO:0006898 | receptor-mediated endocytosis |
BP | IEA | GO:0006958 | complement activation, classical pathway |
BP | TAS | GO:0030449 | regulation of complement activation |
BP | IEA | GO:0045087 | innate immune response |
CC | TAS | GO:0005576 | extracellular region |
CC | HDA | GO:0005615 | extracellular space |
CC | IEA | GO:0016020 | membrane |
CC | HDA | GO:0070062 | extracellular exosome |
Gene expression in normal tissue: CFI
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CFI
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-166658 | Complement cascade |
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-977606 | Regulation of Complement cascade |
kegg | hsa04610 | Complement and coagulation cascades - Homo sapiens (human) |
kegg | hsa05150 | Staphylococcus aureus infection - Homo sapiens (human) |
wikipathways | WP2806 | Human Complement System |
wikipathways | WP3896 | Dengue-2 Interactions with Complement and Coagulation Cascades |
wikipathways | WP558 | Complement and Coagulation Cascades |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD123 | Isoevodiamine | 2 |
iGMDRD945 | ML214 | 2 |
iGMDRD154 | NSC23766 | 2 |
iGMDRD85 | Ursolic acid | 1 |
iGMDRD57 | Chloropentafluorobenzene | 3 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD512 | nutlin 3 | 2 |
iGMDRD248 | BRD4354 | 1 |
iGMDRD263 | AACOCF3 | 3 |
iGMDRD246 | NPC26 | 6 |
iGMDRD286 | Nsc 632839 | 5 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD662 | JQ-1 | 3 |
iGMDRD705 | Nakiterpiosin | 2 |
iGMDRD289 | Parthenolide | 1 |
iGMDRD105 | Triptolide | 5 |
iGMDRD434 | BMS-536924 | 1 |
iGMDRD121 | GMX1778 | 2 |
iGMDRD158 | NSC141540 | 4 |
iGMDRD466 | Chaetocin | 1 |
iGMDRD394 | BX-795 | 2 |
iGMDRD634 | SCHEMBL2608041 | 3 |
iGMDRD193 | Fqi1 | 3 |
iGMDRD781 | Sirolimus | 12 |
iGMDRD126 | Tipifarnib | 3 |
iGMDRD151 | CHM-1 | 2 |
iGMDRD889 | Compound 7d-cis | 3 |
iGMDRD420 | Leucascandrolide A | 2 |
iGMDRD1008 | SR-II-138A | 2 |
iGMDRD690 | PRIMA-1MET | 2 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD451 | Serdemetan | 4 |
iGMDRD100 | Zebularine | 5 |
iGMDRD887 | Compound 23 citrate | 3 |
iGMDRD74 | Idarubicin | 1 |
iGMDRD577 | BIX01294 | 6 |
iGMDRD888 | Compound 44 | 2 |
iGMDRD780 | PP-30 | 3 |
iGMDRD562 | Navitoclax | 6 |
iGMDRD171 | Pemetrexed | 4 |
iGMDRD318 | PAC-1 | 3 |
iGMDRD870 | BRD63610 | 1 |
iGMDRD187 | BRD9876 | 2 |
iGMDRD138 | PX 12 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CFI